Dr. Finegold is a member of the faculty in the Department of Human Genetics. He serves as the co-director of the Multidisciplinary Masters of Public Health Program. He is part of a working group collaborating with Pittsburgh Mercy Behavioral's Operation Safety Net. He has a major research focus on lymphatic vascular biology and genetic variation underlying primary and secondary lymphedema. He has been the co-principal investigator for the Pittsburgh Lymphedema Family Study. He continues as a co-investigator in Dr. Massimo Trucco's studies to rescue newly diagnosed patients with type I diabetes mellitus. He is a member of Dr. Lisa Pan's suicide research group. He also is a member of two analytical chemistry groups developing novel biomolecular sensors and a chemical engineering sensing and modeling group. He serves as the laboratory director for two commercial entities, Ariel Precision Medicine [arielmedicine.com and Signaturedx [signaturedx.com].